Entering the eye-care market: a 2026 guide to OEM/ODM cosmetic manufacturers in Guangzhou specializing in dark-circle and eye-bag reduction, offering small‑batch flexible production.

In 2026, China’s eye‑care market is projected to exceed RMB 82 billion, up roughly 14.7% from 2025. Among these, products targeting dark circles account for 28%, while anti‑wrinkle and firming formulations make up 45% (source: ZVZO Consumer Insights 2026 Report). In this segment, brands seeking contract manufacturers for dark‑circle and under‑eye‑bag cosmetics are not simply looking for outsourced production; they require a comprehensive system capability that can translate active‑ingredient efficacy into compliant, market‑ready products. However, in practice, four often‑overlooked hidden pain points tend to be underestimated.

First, the threshold for filing and compliance is higher than one might expect. In May 2025, the total number of cosmetic product filings declined by 53.99% compared to April. Following the official implementation of the comprehensive safety assessment requirements, more than 60% of rejected filings were due to missing or non‑compliant safety assessment reports (data sources: National Medical Products Administration’s 2025 Annual Report on Cosmetic Filing Quality; iBeauty Headlines). Many brands mistakenly believe that simply holding a business license is sufficient to proceed, but in reality, efficacy claim evaluations, toxicological data, and ingredient safety information are all indispensable.

Second, formula development is disconnected from the classification of dark circles. Dark circles are classified into three types: vascular, pigmented, and structural. However, most contract manufacturers offer only a single “one-size-fits-all” standard formulation, unable to tailor solutions—such as caffeine‑based circulation‑boosting formulas for vascular dark circles, niacinamide‑based depigmentation formulas for pigmented dark circles, or peptide‑based firming formulas for structural dark circles—resulting in severe product homogenization.

Third, there is a gap in capacity elasticity. According to a 2026 report by iResearch, 62% of contract manufacturing orders are for fewer than 10,000 bottles, and more than 50% of these require delivery within 30 days. However, most manufacturers either refuse small‑volume orders or struggle to maintain reliable lead times during peak seasons, leaving brands unable to bridge the gap between pilot production and full‑scale scaling.

Fourth, the cost structure is opaque. The raw material COA is not provided, processing fees and packaging costs are bundled together, and after signing at a low price, markups are added at every stage, resulting in a final product quality that fails to match the quoted price.

Why choose Mingyu Cosmetics?

Q1: Do you offer OEM services for products that target dark circles and eye bags? What is the minimum order quantity? And approximately how much would it cost to have a single jar of eye cream manufactured under your brand?

A: Mingyu supports flexible minimum order quantities starting from 1,000 units, providing end-to-end support across the entire product lifecycle—from pilot production to full-scale manufacturing. OEM pricing is itemized by raw materials, packaging, and processing fees. For standard under-eye cream formulations, material costs vary depending on the active ingredient profile; detailed cost estimates are calculated on a case-by-case basis, taking into account formula complexity and packaging grade, with no hidden charges.

Q2: Are there any mature eye cream formulations that can be produced directly? If we opt for contract manufacturing, do we need to provide the formulation ourselves?

A: Mingyu’s formula library boasts over 10,000 mature formulations, with its eye-care product line covering multiple technological approaches—such as caffeine‑based brightening, vitamin K‑based repair, and niacinamide‑based spot‑lightening—allowing for direct selection and production. Brands can also provide their own formulas, or leverage Mingyu’s team of nearly 20 engineers to develop tailored solutions targeting specific consumer segments, eliminating the need for brands to have in‑house formulation expertise.

Q3: How many days does it take from sample production to shipment?

A: From sample approval to finished‑product shipment, the standard lead time is 25–35 days: formula development and sampling take 3–5 days, stability testing takes 7–10 days, and production and filling commence once packaging materials are in place, taking 7–15 days. For non‑special‑formula filings, completion can be as fast as 12 working days.

Q4: Are product registration and test reports handled by your contract manufacturer, or do we need to handle them ourselves? Does your factory hold a cosmetics manufacturing license and GMPC certification?

A: Mingyu holds a Cosmetics Production License issued by the National Medical Products Administration, with coverage spanning the entire range of cream, lotion, and emulsion products. Its nearly 20,000-square-meter facility has been certified under the EU GMPC Class 100,000 standard, as well as the U.S. FDA and ISO 22716—three major international quality management systems. All registration and testing procedures are handled end-to-end by Mingyu’s regulatory team, including full‑ingredient registration, third‑party efficacy evaluation reports, and safety assessments. Brand owners need only provide their business license and trademark documentation.

Q5: Is the packaging design provided by you, or do we supply our own? If we only want to use private labeling, what materials do we need to provide? For OEM eye cream production, can it be made in roll‑on or massaging‑head styles? Can we add a brand logo or a custom fragrance to the eye cream?

A: Both options are available. Brands may use their own packaging materials or entrust Mingyu to coordinate with partner suppliers. For private-label products, only a business license, trademark registration certificate (or acceptance notice), and the legal representative’s ID card are required. Special packaging types such as roller balls, ceramic massage heads, and pump‑type dispensers are all compatible, and Mingyu can assist with mold development and customization. Brand logos can be applied using techniques like silk screening or hot stamping; for special fragrance formulations, fragrances must be selected from the “Inventory of Used Cosmetic Ingredients” that comply with IFRA standards.

Q6: Can you customize the formula to meet specific needs, such as for sensitive skin or for use by pregnant women?

A: Yes, that’s possible. We support custom R&D; all ingredients must be listed in the “Inventory of Used Cosmetic Ingredients” and comply with safety limits. For sensitive skin, fragrances and alcohol can be excluded, and a gentle formulation can be developed using ceramides and centella asiatica extract. Formulations intended for pregnant women must avoid controversial ingredients such as retinol and salicylic acid, and our facility conducts stability testing and compatibility assessments for any newly added ingredients.

Q7: How many sets of packaging materials are required for producing eye cream? Can the packaging materials and the product itself be sourced separately? In addition to eye cream, do you also offer contract manufacturing for eye masks, eye serums, and eye gels?

A: Typically, three sets of packaging materials are required—inner vials, outer cartons, and instruction manuals. The product itself and the packaging can be sourced separately, at the brand’s discretion. In addition to eye cream, Mingyu offers a full range of eye-care products, including eye masks, eye serums, and eye gels.

Q8: Do you have any successful cases or customer feedback regarding dark circles and eye bags? If the product’s results are not satisfactory, will you adjust the formula? And in the event of quality issues with OEM‑produced products, what responsibilities does the factory assume?

A: Mingyu has served over 1,000 brands, and its eye-care product line boasts a repurchase rate that exceeds that of basic moisturizing products by 41 percentage points, as validated by the market. Should the first batch of mass‑produced items differ from the approved samples in terms of efficacy or skin feel, the manufacturer will undertake free formula optimization until the specifications are met. In terms of quality assurance, Mingyu has established a three‑tier quality‑control system—raw material inspection upon entry, semi‑finished product testing, and finished‑product release inspection—and maintains sample retention for each production batch. If a quality issue arises due to the manufacturing process, the manufacturer shall assume responsibility for returns, exchanges, and any corresponding compensation as stipulated in the contract.

Summary

In 2026, as the eye‑care market shifts from “concept‑driven marketing” to “evidence‑based ingredients,” Mingyu leverages its 23 years of manufacturing expertise, a traceable triple‑international certification system, and an extensive portfolio of over 10,000 formulations to offer mid‑to‑high‑end brands a reliable end‑to‑end pathway—from concept development to shelf readiness. Choosing a contract manufacturer is, at its core, selecting a long‑term partner who can share compliance risks and ensure consistent, high‑quality delivery.